Soranib 200 mg Cipla
€54.00
What is Soranib 200 mg Cipla? – purpose and application
Soranib 200 mg Cipla is a pharmaceutical drug primarily known for its application in treating various forms of cancer, especially renal cell carcinoma. It acts as a multi-kinase inhibitor, targeting specific pathways that tumors utilize for growth and metastasis. In the realm of sports pharmacology, Soranib has gained attention due to its potential effects on athletic performance. Athletes and bodybuilders often seek ways to optimize their performance, and Soranib’s ability to enhance endurance and strength makes it an intriguing option. However, it is crucial to recognize that its primary intent is medical, and using it outside these parameters should be approached with caution.
Physiological impact of Soranib 200 mg Cipla – metabolism and muscle response
Soranib affects the body’s metabolism by inhibiting certain signaling pathways that influence cell growth. As it interacts with the vascular endothelial growth factor (VEGF) and other receptors, it leads to changes in blood flow and nutrient delivery to muscles. This can facilitate improved oxygenation and nutrient supply, potentially affecting endurance levels. Studies have illustrated that Soranib can induce a state where muscle fatigue is delayed, thanks to enhanced metabolic efficiency. Moreover, by modulating various molecular mechanisms in muscle tissue, it contributes to a heightened response during intensive workouts.
Benefits of using Soranib 200 mg Cipla – increased endurance and strength
Athletes who utilize Soranib 200 mg Cipla often report significant improvements in both endurance and overall strength. The increase in vascularization due to enhanced blood flow can lead to a marked decrease in fatigue during prolonged physical exertion. As muscles receive more oxygen and essential nutrients, the capacity for sustained performance rises, enabling athletes to train harder and for longer durations. Furthermore, some users observe accelerated muscle recovery, allowing for quicker training adaptations and progress over time. However, it’s essential to note that these benefits can vary widely among individuals, and the long-term impact on health remains a concern.
Contraindications – who should not use it
Despite its potential advantages, Soranib 200 mg Cipla is not suitable for everyone. Individuals with pre-existing health conditions, such as heart disease or hypertension, should avoid its use due to risks of adverse effects. Pregnant or breastfeeding women are also advised against its use, as its impact on fetal development is not fully understood. Additionally, those with a history of kidney or liver issues may face increased complications. Always consult with a healthcare professional before considering Soranib, as misuse can lead to significant health risks.
How to buy Soranib 200 mg Cipla safely in our shop – easy ordering and fast delivery.
If you’re considering Soranib 200 mg Cipla for athletic enhancement, it’s vital to purchase it from a reputable source. Our shop provides a secure platform for ordering Soranib, ensuring that you receive genuine products, free from counterfeit risks. We adhere to strict quality control measures, guaranteeing that every order meets safety standards. With our user-friendly online system, you can easily navigate through our inventory and place your order with minimal hassle. To ensure a smooth experience, follow these steps:
- Visit our website and browse the available options of Soranib 200 mg Cipla.
- Add the desired quantity to your shopping cart.
- Proceed to checkout and provide the necessary information.
- Choose your preferred payment method for secure transactions.
- Confirm your order and wait for our speedy delivery to your address.
Prioritizing safety and quality ensures that you can make informed decisions regarding your performance-enhancing regimen.
| Active substance | Sorafenib |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | Yes, can cause liver injury |
| Lab Test | Liver function tests are recommended |
| Strength | 200mg |
| Also known as | BAY 43-9006 |
| Blood pressure | Can cause hypertension |
| Trade name | Nexavar |
| Storage conditions | Store at room temperature, protect from moisture |
| Chemical name | 4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpyridine-2-carboxamide |
| Formula | C21H16ClF3N4O3 |
| Substance class | Kinase inhibitor |
| Main action | Antineoplastic agent |
| Half-life | Approximately 25 to 48 hours |
| Dosage (medical) | Typically 400 mg twice daily |
| Dosage (sports) | Not applicable |
| Effects | Inhibits tumor cell proliferation and angiogenesis |
| Side effects | Diarrhea, rash, fatigue, hypertension, hand-foot skin reactions |
| Use in sports | None |
| Manufacturer | Cipla Ltd. |
| Packing | 30 tabs/bottle |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |



Reviews
There are no reviews yet.